Protara Therapeutics (TARA) Insider Trading & Ownership → Why Is Gold On a MASSIVE rally? (From Huge Alerts) (Ad) Free TARA Stock Alerts $3.09 -0.65 (-17.38%) (As of 05/17/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Protara Therapeutics (NASDAQ:TARA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage18.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$94,554.00 Get TARA Insider Trade Alerts Want to know when executives and insiders are buying or selling Protara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TARA Insider Buying and Selling by Quarter Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself Protara Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/9/2024Opaleye Management Inc.Major ShareholderSell30,600$3.09$94,554.00 (Data available from 1/1/2013 forward) TARA Insider Trading Activity - Frequently Asked Questions Who is on Protara Therapeutics's Insider Roster? The list of insiders at Protara Therapeutics includes Jesse Shefferman, Luke M Beshar, Martin Sebastian Olivo, and Opaleye Management Inc.. Learn more on insiders at TARA. What percentage of Protara Therapeutics stock is owned by insiders? 18.40% of Protara Therapeutics stock is owned by insiders. Learn more on TARA's insider holdings. Which Protara Therapeutics insiders have been buying company stock? The following insiders have purchased TARA shares in the last 24 months: Jesse Shefferman ($34,809.60), Luke M Beshar ($31,000.00), and Opaleye Management Inc. ($66,068.00). How much insider buying is happening at Protara Therapeutics? Insiders have purchased a total of 35,665 TARA shares in the last 24 months for a total of $131,877.60 bought. Which Protara Therapeutics insiders have been selling company stock? The following insider sold TARA shares in the last 24 months: Opaleye Management Inc. ($94,554.00). How much insider selling is happening at Protara Therapeutics? Insiders have sold a total of 30,600 Protara Therapeutics shares in the last 24 months for a total of $94,554.00 sold. More Insider Trading Tools from MarketBeat Related Companies: TSBX Insider Selling ENTX Insider Selling ATRA Insider Selling IKNA Insider Selling CSBR Insider Selling CVM Insider Selling CDTX Insider Selling CGTX Insider Selling AVRO Insider Selling LENZ Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:TARA) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsA ‘DeFi Summer’ Projected!Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBiden Nomination CANCELED?The Freeport SocietyThe #1 Investment of the Decade… Porter & CompanyUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
